PKR: A Kinase to Remember

Shunit Gal-Ben-Ari1, Iliana Barrera1, Marcelo Ehrlich2

  • 1Laboratory of Molecular and Cellular Mechanisms Underlying Learning and Memory, Sagol Department of Neurobiology, University of Haifa, Haifa, Israel.

Insights

Protein kinase R (PKR) is a key regulator linking metabolic stress and aging. Targeting PKR may offer new therapeutic strategies for age-related diseases like cancer and neurodegeneration.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Gerontology

Background:

  • Aging is a significant risk factor for numerous diseases, including metabolic syndrome, cancer, inflammation, and neurodegeneration.
  • Understanding the common mechanisms underlying aging is crucial for developing strategies against age-related diseases.
  • Aging can be biochemically defined as prolonged metabolic stress and the cellular responses to it.

Purpose of the Study:

  • To investigate the role of protein kinase R (PKR) in mediating the effects of aging and metabolic stress.
  • To explore PKR's function in regulating cellular processes relevant to cancer, inflammation, and brain function.
  • To identify PKR as a potential therapeutic target for age-related conditions.

Main Methods:

  • Literature review and data integration from open data sources.
  • Analysis of PKR's role in metabolic information transfer and cellular regulation.
  • Examination of signaling cascades upstream and downstream of PKR.

Main Results:

  • PKR acts as a central regulator, transferring metabolic information and influencing cellular functions.
  • Imbalanced PKR activation is linked to metabolic parameters, forming a feedforward loop.
  • PKR's involvement is highlighted in cancer, inflammation, and brain function.

Conclusions:

  • PKR plays a critical role in cellular responses to metabolic stress and aging.
  • Manipulating PKR expression or activation presents a potential therapeutic avenue.
  • Targeting PKR could help shift detrimental age/metabolic-dependent states towards healthier outcomes.

Related Concept Videos

Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
15.1K
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

4.5K
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
18.5K
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
8.5K
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers01:26

Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers

Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
526
What are Second Messengers?01:12

What are Second Messengers?

Because many receptor binding ligands are hydrophilic, they do not cross the cell membrane and thus their message must be relayed to a second messenger on the inside. There are several second messenger pathways, each with their own way of relaying information. G-protein coupled receptors can activate both phosphoinositol and cyclic AMP (cAMP) second messenger pathways. The phosphoinositol path is active when the receptor induces phospholipase C to hydrolyze the phospholipid,...
90.6K